CHAPTER 1 INTRODUCTION

CHAPTER 2 EXECUTIVE SUMMARY

2.1. KEY FINDINGS OF THE STUDY
2.1. CXO PERSPECTIVE

CHAPTER 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top wining strategies

3.2.1.1. Competitive intelligence of companies and their strategies

3.2.2. Top investment pockets

3.3. MARKET DYNAMICS

3.3.1. Drivers

3.3.1.1. Increasing incidence of diabetes
3.3.1.2. Rising geriatric population
3.3.1.3. Technological advancements

3.3.2. Restrains

3.3.2.1. Not suitable for combination insulin

3.3.3. Opportunities

3.3.3.1. Untapped opportunities in emerging nations

3.3.4. Impact analysis

3.4. MARKET SHARE ANALYSIS, 2016
3.5. GOVERNMENT REGULATIONS
3.6. CLINICAL TRIALS

CHAPTER 4 SMART INSULIN PENS MARKET, BY TYPE

4.1. OVERVIEW

4.1.1. Market size and forecast

4.2. FIRST GENERATION PENS

4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size and forecast

4.3. SECOND GENERATION PENS

4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size and forecast
4.3.4. Bluetooth-enabled pens

4.3.4.1. Market size and forecast

4.3.5. USB connected pens

4.3.5.1. Market size and forecast

CHAPTER 5 SMART INSULIN PENS MARKET, BY USABILITY

5.1. OVERVIEW

5.1.1. Market size and forecast

5.2. PRE-FILLED PENS

5.2.1. Market size and forecast

5.3. REUSABLE PENS

5.3.1. Market size and forecast

CHAPTER 6 SMART INSULIN PENS MARKET, BY END-USER

6.1. OVERVIEW

6.1.1. Market size and forecast

6.2. HOSPITALS & CLINICS

6.2.1. Market size and forecast

6.3. AMBULATORY SURGICAL CENTERS

6.3.1. Market size and forecast

6.4. HOME CARE SETTINGS

6.4.1. Market size and forecast

CHAPTER 7 SMART INSULIN PENS MARKET, BY REGION

7.1. OVERVIEW

7.1.1. Market size and forecast

7.2. NORTH AMERICA

7.2.1. Key market trends
7.2.2. Growth factors and opportunities
7.2.3. Market size and forecast

7.2.3.1. U.S. market size and forecast
7.2.3.2. Canada market size and forecast
7.2.3.3. Mexico market size and forecast

7.3. EUROPE

7.3.1. Key market trends
7.3.2. Growth factors and opportunities
7.3.3. Market size and forecast

7.3.3.1. Germany market size and forecast
7.3.3.2. France market size and forecast
7.3.3.3. UK market size and forecast
7.3.3.4. Italy market size and forecast
7.3.3.5. Spain market size and forecast
7.3.3.6. Rest of Europe market size and forecast

7.4. ASIA-PACIFIC

7.4.1. Key market trends
7.4.2. Growth factors and opportunities
7.4.3. Market size and forecast

7.4.3.1. Japan market size and forecast
7.4.3.2. China market size and forecast
7.4.3.3. India market size and forecast
7.4.3.4. Australia market size and forecast
7.4.3.5. Rest of Asia-Pacific market size and forecast

7.5. LAMEA

7.5.1. Key market trends
7.5.2. Growth factors and opportunities
7.5.3. Market size and forecast

7.5.3.1. Brazil market size and forecast
7.5.3.2. South Africa market size and forecast
7.5.3.3. Saudi Arabia market size and forecast
7.5.3.4. Rest of LAMEA market size and forecast

CHAPTER 8 COMPANY PROFILES

8.1. ELI LILLY AND COMPANY

8.1.1. Company overview
8.1.2. Operating business segments
8.1.3. Business performance
8.1.4. Key strategic moves and developments

8.2. NOVO NORDISK

8.2.1. Company overview
8.2.2. Operating business segments
8.2.3. Business performance
8.2.4. Key strategic moves and developments

8.3. COMPANION MEDICAL

8.3.1. Company overview
8.3.2. Operating business segments
8.3.3. Business performance
8.3.4. Key strategic moves and developments

8.4. DIAMESCO

8.4.1. Company overview
8.4.2. Operating business segments
8.4.3. Business performance
8.4.4. Key strategic moves and developments

8.5. EMPERRA GMBH

8.5.1. Company overview
8.5.2. Operating business segments
8.5.3. Business performance
8.5.4. Key strategic moves and developments